<DOC>
	<DOCNO>NCT00444548</DOCNO>
	<brief_summary>[ S , S ] -Reboxetine use evaluate pharmacodynamic change urethral function healthy volunteer use novel methodology</brief_summary>
	<brief_title>Evaluation A Novel Methodology Assessment Urethral Function Using S , S-Reboxetine Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Reboxetine</mesh_term>
	<criteria>Healthy female subject , age 1865 year . Subjects must nonpregnant nonlactating , either post menopausal ( great 1 year without menses ) , surgically sterilize , use another acceptable form contraception . Subjects child bear potential must confirm negative pregnancy test screen prior commence study period . Evidence history clinically significant disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Subjects clinically significant abnormality follow review laboratory data , urinalysis physical examination .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Equipment</keyword>
	<keyword>Supplies</keyword>
</DOC>